Taking Aim at HER3 in Lung Cancers Resistant to EGFR Inhibitors

Gain expert perspectives on the evolving role of HER3 in EGFR-mutated advanced NSCLC including the role of HER3-targeted therapies in the setting of EGFR TKI resistance with this educational program featuring a series of short interactive virtual presentations with downloadable slidesets and a multidisciplinary audio podcast.

Share

Program Content

Activities

Slides: ADCs in Lung Cancer Care
Antibody–Drug Conjugates in Lung Cancer Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 07, 2022

Expires: February 06, 2023

Slides: HER3 in Lung Cancer
Role of HER3 in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 27, 2021

Expires: October 26, 2022

Slides: EGFR TKI Resistance
Mechanisms of Resistance to EGFR TKI Therapy in Advanced Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2021

Expires: November 18, 2022

Slides: Tx After EGFR TKI
Treatment for EGFR-Mutant Lung Cancer After Progression on EGFR TKI
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2021

Expires: November 18, 2022

Activities

<i>EGFR</i>+ NSCLC: Multidisciplinary Overview
Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: January 26, 2022

Expires: January 25, 2023

Faculty

cover img faculity

Elise Hitron, MSN, FNP-C

Nurse Practitioner
Phase I Clinical Trials at Winship Cancer Institute
Atlanta, Georgia

cover img faculity

Frank Schneider, MD

Associate Professor of Pathology
Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Helena Yu, MD

Associate Attending
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.